Best Practice & Research Clinical Obstetrics & Gynaecology
Volume 24, Issue 2 , Pages 139-148 , April 2010

The XY female

  • Lina Michala, MRCOG (Consultant Gynaecologist)

      Affiliations

    • Alexandras Hospital, 6 Lampsakou street, Athens, Greece
    • ,
  • Sarah M. Creighton, MD, FRCOG (Consultant Gynaecologist)

      Affiliations

    • UCL Elizabeth Garrett Anderson Institute for Women's Health, 250 Euston Road London NW1 2PG, UK
    • Corresponding Author InformationCorresponding author.

References 

  1. Sinclair AH, Berta P, Palmer MS, et al. A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motif. Nature. 1990;346(6281):240–244
  2. Cameron FJ, Sinclair AH. Mutations in SRY and SOX9: testis-determining genes. Hum Mutat. 1997;9(5):388–395
  3. Rey R, Picard JY. Embryology and endocrinology of genital development. Baillieres Clin Endocrinol Metab. 1998;12(1):17–33
  4. Zhu YS, Katz MD, Imperato-McGinley J. Natural potent androgens: lessons from human genetic models. Baillieres Clin Endocrinol Metab. 1998;12(1):83–113
  5. Odeh M, Granin V, Kais M, et al. Sonographic fetal sex determination. Obstet Gynecol Surv. 2009;64(1):50–57
  6. Hughes IA, Houk C, Ahmed SF, et al. Consensus statement on management of intersex disorders. Arch Dis Child. 2006;91(7):554–563
  7. Lee PA, Houk CP, Ahmed SF, et al. Consensus statement on management of intersex disorders. International Consensus Conference on Intersex. Pediatrics. 2006;118(2):e488–e500
  8. Hughes IA. Disorders of sex development: a new definition and classification. Best Pract Res Clin Endocrinol Metab. 2008;22(1):119–134
  9. Swyer GI. Male pseudohermaphroditism: a hitherto undescribed form. Br Med J. 1955;2(4941):709–712
  10. Lin L, Achermann JC. Steroidogenic factor-1 (SF-1, Ad4BP, NR5A1) and disorders of testis development. Sex Dev. 2008;2(4-5):200–209
  11. Michala L, Aslam N, Conway GS, Creighton SM. The clandestine uterus, or how the uterus escapes detection prior to puberty, BJOG, in press, doi:10.1111/j.1471-0528.2009.02413.x.
  12. Sarafoglou K, Ostrer H. Clinical review 111: familial sex reversal: a review. J Clin Endocrinol Metab. 2000;85(2):483–493
  13. Michala L, Goswami D, Creighton SM, et al. Swyer syndrome: presentation and outcomes. BJOG. 2008;115(6):737–741
  14. Selvaraj K, Ganesh V, Selvaraj P. Successful pregnancy in a patient with a 46, XY karyotype. Fertil Steril. 2002;78(2):419–420
  15. Kan AK, Abdalla HI, Oskarsson T. Two successful pregnancies in a 46, XY patient. Hum Reprod. 1997;12(7):1434–1435
  16. Chen MJ, Yang JH, Mao TL, et al. Successful pregnancy in a gonadectomized woman with 46, XY gonadal dysgenesis and gonadoblastoma. Fertil Steril. 2005;84(1):217
  17. Esegbona G, Cutner A, Cuckow P, et al. Laparoscopic gonadectomy in paediatric and adolescent girls with intersex disorders. BJOG. 2003;110(2):210–212
  18. Pandis GK, Michala L, Creighton SM, et al. Minimal access surgery in adolescent gynaecology. BJOG. 2009;116(2):214–219
  19. Niaudet P, Gubler MC. WT1 and glomerular diseases. Pediatr Nephrol. 2006;21(11):1653–1660
  20. Auber F, Lortat-Jacob S, Sarnacki S, et al. Surgical management and genotype/phenotype correlations in WT1 gene-related diseases (Drash, Frasier syndromes). J Pediatr Surg. 2003;38(1):124–129
  21. Barbaux S, Niaudet P, Gubler MC, et al. Donor splice-site mutations in WT1 are responsible for Frasier syndrome. Nat Genet. 1997;17(4):467–470
  22. Koziell A, Charmandari E, Hindmarsh PC, et al. Frasier syndrome, part of the Denys Drash continuum or simply a WT1 gene associated disorder of intersex and nephropathy?. Clin Endocrinol (Oxf). 2000;52(4):519–524
  23. Josso N, Briard ML. Embryonic testicular regression syndrome: variable phenotypic expression in siblings. J Pediatr. 1980;97(2):200–204
  24. Law H, Mushtaq I, Wingrove K, et al. Histopathological features of testicular regression syndrome: relation to patient age and implications for management. Fetal Pediatr Pathol. 2006;25(2):119–129
  25. Bose HS, Sugawara T, Strauss JF, et al. The pathophysiology and genetics of congenital lipoid adrenal hyperplasia. International Congenital Lipoid Adrenal Hyperplasia Consortium. N Engl J Med. 1996;335(25):1870–1878
  26. Imperato-McGinley J, Guerrero L, Gautier T, et al. Steroid 5 alpha-reductase deficiency in man: an inherited form of male pseudohermaphroditism. Science. 1974;186(4170):1213–1215
  27. Wilson JD, Griffin JE, Russell DW. Steroid 5 alpha-reductase 2 deficiency. Endocr Rev. 1993;14(5):577–593
  28. Crouch NS, Liao LM, Woodhouse CR, et al. Sexual function and genital sensitivity following feminizing genitoplasty for congenital adrenal hyperplasia. J Urol. 2008;179(2):634–638
  29. Creighton SM, Minto CL, Steele SJ. Objective cosmetic and anatomical outcomes at adolescence of feminising surgery for ambiguous genitalia done in childhood. Lancet. 2001;358(9276):124–125
  30. Michala L, Cutner A, Creighton SM. Surgical approaches to treating vaginal agenesis. BJOG. 2007;114(12):1455–1459
  31. Giannesi A, Marchiole P, Benchaib M, et al. Sexuality after laparoscopic Davydov in patients affected by congenital complete vaginal agenesis associated with uterine agenesis or hypoplasia. Hum Reprod. 2005;20(10):2954–2957
  32. Rosler A, Silverstein S, Abeliovich DA. (R80Q) mutation in 17 beta-hydroxysteroid dehydrogenase type 3 gene among Arabs of Israel is associated with pseudohermaphroditism in males and normal asymptomatic females. J Clin Endocrinol Metab. 1996;81(5):1827–1831
  33. Lee YS, Kirk JM, Stanhope RG, et al. Phenotypic variability in 17beta-hydroxysteroid dehydrogenase-3 deficiency and diagnostic pitfalls. Clin Endocrinol (Oxf). 2007;67(1):20–28
  34. Boehmer AL, Brinkmann AO, Sandkuijl LA, et al. 17Beta-hydroxysteroid dehydrogenase-3 deficiency: diagnosis, phenotypic variability, population genetics, and worldwide distribution of ancient and de novo mutations. J Clin Endocrinol Metab. 1999;84(12):4713–4721
  35. Faisal AS, Iqbal A, Hughes IA. The testosterone:androstenedione ratio in male undermasculinization. Clin Endocrinol (Oxf). 2000;53(6):697–702
  36. Quigley CA, De BA, Marschke KB, el-Awady MK, Wilson EM , French FS. Androgen receptor defects: historical, clinical, and molecular perspectives. Endocr Rev. 1995;16(3):271–321
  37. Morris JM. The syndrome of testicular feminization in male pseudohermaphrodites. Am J Obstet Gynecol. 1953;65(6):1192–1211
  38. Hannema SE, Scott IS, Rajpert-De ME, et al. Testicular development in the complete androgen insensitivity syndrome. J Pathol. 2006;208(4):518–527
  39. Deeb A, Hughes IA. Inguinal hernia in female infants: a cue to check the sex chromosomes?. BJU Int. 2005;96(3):401–403
  40. Hughes IA, Deeb A. Androgen resistance. Best Pract Res Clin Endocrinol Metab. 2006;20(4):577–598
  41. Han TS, Goswami D, Trikudanathan S, et al. Comparison of bone mineral density and body proportions between women with complete androgen insensitivity syndrome and women with gonadal dysgenesis. Eur J Endocrinol. 2008;159(2):179–185
  42. Wisniewski AB, Migeon CJ. Long-term perspectives for 46, XY patients affected by complete androgen insensitivity syndrome or congenital micropenis. Semin Reprod Med. 2002;20(3):297–304
  43. Minto CL, Liao KL, Conway GS, et al. Sexual function in women with complete androgen insensitivity syndrome. Fertil Steril. 2003;80(1):157–164
  44. Ismail-Pratt IS, Bikoo M, Liao LM, et al. Normalization of the vagina by dilator treatment alone in Complete Androgen Insensitivity Syndrome and Mayer-Rokitansky-Kuster-Hauser Syndrome. Hum Reprod. 2007;22(7):2020–2024
  45. Frank RT. The formation of artificial vagina without operation. Am J Obstet Gynecol. 1938;35:1053–1055
  46. Fedele L, Bianchi S, Zanconato G, et al. Laparoscopic creation of a neovagina in patients with Rokitansky syndrome: analysis of 52 cases. Fertil Steril. 2000;74(2):384–389
  47. Boehmer AL, Brinkmann O, Bruggenwirth H, et al. Genotype versus phenotype in families with androgen insensitivity syndrome. J Clin Endocrinol Metab. 2001;86(9):4151–4160
  48. Kohler B, Lumbroso S, Leger J, et al. Androgen insensitivity syndrome: somatic mosaicism of the androgen receptor in seven families and consequences for sex assignment and genetic counseling. J Clin Endocrinol Metab. 2005;90(1):106–111
  49. Boehmer AL, Brinkmann AO, Nijman RM, et al. Phenotypic variation in a family with partial androgen insensitivity syndrome explained by differences in 5alpha dihydrotestosterone availability. J Clin Endocrinol Metab. 2001;86(3):1240–1246
  50. Piersma D, Verhoef-Post M, Berns EM, et al. LH receptor gene mutations and polymorphisms: an overview. Mol Cell Endocrinol. 2007;260-262:282–286
  51. Themmen AP, Brunner HG. Luteinizing hormone receptor mutations and sex differentiation. Eur J Endocrinol. 1996;134(5):533–540
  52. Money J, Hampson JG, Hampson JL. Hermaphroditism: recommendations concerning assignment of sex, change of sex and psychologic management. Bull Johns Hopkins Hosp. 1955;97(4):284–300
  53. Conn J, Gillam L, Conway GS. Revealing the diagnosis of androgen insensitivity syndrome in adulthood. BMJ. 2005;331(7517):628–630

PII: S1521-6934(09)00123-0

doi: 10.1016/j.bpobgyn.2009.09.009

Best Practice & Research Clinical Obstetrics & Gynaecology
Volume 24, Issue 2 , Pages 139-148 , April 2010

Article Tools